Stock Market News1 month Merck Ends Development of Two Experimental Cancer Drugs Zacks
MRK’s decision to discontinue the development of two cancer drugs follows a series of setbacks in multiple late-stage studies.
XMRK’s decision to discontinue the development of two cancer drugs follows a series of setbacks in multiple late-stage studies.
X